Skip to main content

Ovarian Embryonal Carcinoma clinical trials at UCSF

1 research study open to eligible people

Ovarian embryonal carcinoma is a rare type of ovarian cancer. UCSF is conducting a trial on how well doctors can track this disease with active surveillance. This study also looks at the effects of drugs like Bleomycin, Etoposide, Carboplatin, or Cisplatin on patients.

Showing trials for
  • Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

    open to all eligible people

    This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Drugs used in chemotherapy, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.

    Oakland, California and other locations

Our lead scientists for Ovarian Embryonal Carcinoma research studies include .

Last updated: